PubRank

Mimoun Azzouz

Author PubWeight™ 21.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med 2005 2.80
2 Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy. Sci Transl Med 2010 2.02
3 Current developments in gene therapy for amyotrophic lateral sclerosis. Expert Opin Biol Ther 2015 1.43
4 Retinoic acid receptor beta2 promotes functional regeneration of sensory axons in the spinal cord. Nat Neurosci 2005 1.31
5 Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia. Sci Transl Med 2009 1.25
6 Transduction patterns of pseudotyped lentiviral vectors in the nervous system. Mol Ther 2004 1.11
7 PTEN depletion rescues axonal growth defect and improves survival in SMN-deficient motor neurons. Hum Mol Genet 2010 1.06
8 Optimised and rapid pre-clinical screening in the SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS). PLoS One 2011 1.00
9 Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain 2011 1.00
10 Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model. Eur J Neurosci 2005 0.95
11 Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1(G93A) transgenic mice. Neurobiol Dis 2004 0.92
12 Encapsulation of biomacromolecules within polymersomes by electroporation. Angew Chem Int Ed Engl 2012 0.90
13 Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis. Mol Ther 2013 0.85
14 Gene therapy: a promising approach to treating spinal muscular atrophy. Hum Gene Ther 2014 0.84
15 Development and applications of non-HIV-based lentiviral vectors in neurological disorders. Curr Gene Ther 2008 0.83
16 Therapeutic gene silencing in neurological disorders, using interfering RNA. J Mol Med (Berl) 2005 0.83
17 Gene therapy for neurodegenerative diseases based on lentiviral vectors. Prog Brain Res 2009 0.81
18 Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors. Clin Sci (Lond) 2006 0.80
19 Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro. Neurobiol Dis 2005 0.75
20 Corrigendum: Comparison of stimulus-evoked cerebral hemodynamics in the awake mouse and under a novel anesthetic regime. Sci Rep 2015 0.75